Answers are grounded in this paper and cite their sources.
High cancer drug prices continue to be a significant problem in the United States despite the existence of remedial solutions that can be readily implemented with appropriate legislation. See also pages 1313‐23.
No takes yet. Share an insight, caveat, or question.
Kantarjian et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: